Railton R, Rodger J C, Small D R, Harrower A D
Eur J Nucl Med. 1987;13(2):63-6. doi: 10.1007/BF00256017.
We have evaluated 123I-heptadecanoic acid for myocardial scintigraphy in the diagnosis of coronary heart disease by comparing the results obtained with it in subject groups with high and low probabilities of disease. We conclude that although some patients in the former group can be identified, the test is neither sufficiently sensitive nor specific for routine clinical use.
我们通过比较在疾病高概率和低概率受试者组中使用123I-十七烷酸进行心肌闪烁显像诊断冠心病所获得的结果,对其进行了评估。我们得出结论,虽然前一组中的一些患者可以被识别出来,但该检测对于常规临床应用而言,既不够敏感也不够特异。